vs

Side-by-side financial comparison of AgEagle Aerial Systems Inc. (UAVS) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Vivos Therapeutics, Inc. is the larger business by last-quarter revenue ($3.8M vs $2.0M, roughly 1.9× AgEagle Aerial Systems Inc.). AgEagle Aerial Systems Inc. runs the higher net margin — -132.7% vs -180.3%, a 47.5% gap on every dollar of revenue. On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -40.0%). AgEagle Aerial Systems Inc. produced more free cash flow last quarter ($-3.3M vs $-5.3M). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -17.9%).

Elbit Systems Ltd. is an Israel-based international military technology company and defense contractor. Founded in 1966 by Elron, Elbit Systems is the primary provider of the Israeli military's land-based equipment and unmanned aerial vehicles. It is an important company within the defense industry of Israel.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

UAVS vs VVOS — Head-to-Head

Bigger by revenue
VVOS
VVOS
1.9× larger
VVOS
$3.8M
$2.0M
UAVS
Growing faster (revenue YoY)
VVOS
VVOS
+43.4% gap
VVOS
3.4%
-40.0%
UAVS
Higher net margin
UAVS
UAVS
47.5% more per $
UAVS
-132.7%
-180.3%
VVOS
More free cash flow
UAVS
UAVS
$2.0M more FCF
UAVS
$-3.3M
$-5.3M
VVOS
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-17.9%
UAVS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
UAVS
UAVS
VVOS
VVOS
Revenue
$2.0M
$3.8M
Net Profit
$-2.6M
$-6.9M
Gross Margin
38.5%
78.1%
Operating Margin
-160.1%
-166.8%
Net Margin
-132.7%
-180.3%
Revenue YoY
-40.0%
3.4%
Net Profit YoY
24.4%
-143.8%
EPS (diluted)
$-0.09
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UAVS
UAVS
VVOS
VVOS
Q4 25
$3.8M
Q3 25
$2.0M
$6.8M
Q2 25
$4.2M
$3.8M
Q1 25
$3.6M
$3.0M
Q4 24
$2.8M
$3.7M
Q3 24
$3.3M
$3.9M
Q2 24
$3.4M
$4.1M
Q1 24
$3.9M
$3.4M
Net Profit
UAVS
UAVS
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$-2.6M
$-5.4M
Q2 25
$-1.3M
$-5.0M
Q1 25
$7.1M
$-3.9M
Q4 24
$-22.3M
$-2.8M
Q3 24
$-3.5M
$-2.6M
Q2 24
$-2.9M
$-1.9M
Q1 24
$-6.3M
$-3.8M
Gross Margin
UAVS
UAVS
VVOS
VVOS
Q4 25
78.1%
Q3 25
38.5%
58.0%
Q2 25
55.7%
55.2%
Q1 25
58.5%
50.0%
Q4 24
40.6%
56.7%
Q3 24
49.7%
60.5%
Q2 24
45.8%
65.4%
Q1 24
50.2%
56.7%
Operating Margin
UAVS
UAVS
VVOS
VVOS
Q4 25
-166.8%
Q3 25
-160.1%
-69.8%
Q2 25
-49.3%
-127.4%
Q1 25
-27.5%
-129.9%
Q4 24
-207.0%
-75.9%
Q3 24
-56.7%
-68.5%
Q2 24
-74.9%
-47.8%
Q1 24
-61.5%
-110.7%
Net Margin
UAVS
UAVS
VVOS
VVOS
Q4 25
-180.3%
Q3 25
-132.7%
-79.6%
Q2 25
-30.5%
-131.2%
Q1 25
193.5%
-128.1%
Q4 24
-791.9%
-76.4%
Q3 24
-105.3%
-67.8%
Q2 24
-86.4%
-47.6%
Q1 24
-162.2%
-110.1%
EPS (diluted)
UAVS
UAVS
VVOS
VVOS
Q4 25
$-0.58
Q3 25
$-0.09
$-0.49
Q2 25
$-0.32
$-0.55
Q1 25
$-0.09
$-0.45
Q4 24
$52.35
$0.41
Q3 24
$-16.03
$-0.40
Q2 24
$-12.06
$-0.60
Q1 24
$-70.50
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UAVS
UAVS
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$28.3M
$-1.5M
Total Assets
$34.5M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UAVS
UAVS
VVOS
VVOS
Q4 25
$2.0M
Q3 25
$3.1M
Q2 25
$4.4M
Q1 25
$3.8M
$2.3M
Q4 24
$3.6M
$6.3M
Q3 24
$265.1K
$6.3M
Q2 24
$977.2K
$6.9M
Q1 24
$822.9K
$2.6M
Total Debt
UAVS
UAVS
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
$420.4K
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
UAVS
UAVS
VVOS
VVOS
Q4 25
$-1.5M
Q3 25
$28.3M
$2.5M
Q2 25
$16.3M
$4.6M
Q1 25
$4.2M
$4.4M
Q4 24
$-5.7M
$8.0M
Q3 24
$6.2M
$7.7M
Q2 24
$8.1M
$6.3M
Q1 24
$9.1M
$582.0K
Total Assets
UAVS
UAVS
VVOS
VVOS
Q4 25
$25.2M
Q3 25
$34.5M
$25.6M
Q2 25
$23.2M
$26.0M
Q1 25
$20.2M
$11.3M
Q4 24
$20.6M
$15.3M
Q3 24
$22.0M
$15.3M
Q2 24
$22.8M
$15.8M
Q1 24
$23.2M
$11.8M
Debt / Equity
UAVS
UAVS
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
0.10×
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UAVS
UAVS
VVOS
VVOS
Operating Cash FlowLast quarter
$-3.3M
$-3.8M
Free Cash FlowOCF − Capex
$-3.3M
$-5.3M
FCF MarginFCF / Revenue
-168.0%
-139.7%
Capex IntensityCapex / Revenue
0.7%
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.9M
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UAVS
UAVS
VVOS
VVOS
Q4 25
$-3.8M
Q3 25
$-3.3M
$-4.2M
Q2 25
$-2.7M
$-3.5M
Q1 25
$-1.3M
$-3.8M
Q4 24
$-2.5M
$-2.9M
Q3 24
$-1.1M
$-4.2M
Q2 24
$-1.4M
$-3.0M
Q1 24
$-1.6M
$-2.5M
Free Cash Flow
UAVS
UAVS
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$-3.3M
$-4.2M
Q2 25
$-2.8M
$-4.3M
Q1 25
$-1.3M
$-3.9M
Q4 24
$-2.5M
$-3.1M
Q3 24
$-1.1M
$-4.4M
Q2 24
$-1.4M
$-3.1M
Q1 24
$-1.6M
$-2.7M
FCF Margin
UAVS
UAVS
VVOS
VVOS
Q4 25
-139.7%
Q3 25
-168.0%
-62.6%
Q2 25
-65.7%
-111.6%
Q1 25
-35.8%
-129.9%
Q4 24
-89.7%
-84.0%
Q3 24
-32.7%
-113.4%
Q2 24
-42.5%
-76.7%
Q1 24
-40.5%
-78.0%
Capex Intensity
UAVS
UAVS
VVOS
VVOS
Q4 25
40.0%
Q3 25
0.7%
1.2%
Q2 25
0.3%
20.2%
Q1 25
0.3%
4.0%
Q4 24
0.5%
4.5%
Q3 24
0.0%
5.0%
Q2 24
0.4%
1.5%
Q1 24
0.6%
4.4%
Cash Conversion
UAVS
UAVS
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
-0.18×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UAVS
UAVS

Drones Segment$1.1M54%
Other$912.5K46%

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons